App-Quantinova.ai

Il-6 in Aortic Stenosis: Amplification Loop Between Inflammation and Calcification

Marie-Chloe Boulanger - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Calcific Aortic Valve Disease

N/A

Impact of Black Race on Progression to End-Stage Renal Disease Despite Similar Outcomes for Cardiovascular Morbidity and Mortality: The TREAT Study

John McMurray - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Microvascular complications of diabetes 1

Aranesp

Remote Ischemic Preconditioning Does Not Affect Skeletal Muscle Energy Metabolism Measured by 31-Phosphorus Magnetic Resonance Spectroscopy: A Randomized Crossover Trial

Jessica Caterini - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Angiology

Ischemia-reperfusion injury

N/A

Impact of Plasma Lipoprotein(a) Level on the Progression of Aortic Stenosis - The PROGRESSA Study

Christophe Thebault - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Calcific Aortic Valve Disease

N/A

Comparison of Extended-Release Niacin versus Placebo in Statin-Treated Patients With Low Baseline Levels of HDL-C and Well-Controlled on-Treatment LDL-C: Extended One-Year Follow-Up Outcomes From AIM-HIGH

William E Boden - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Acute Coronary Syndromes

simvastatin + ezetimibe

Autophagy Regulates Vascular Smooth Muscle Cell Phenotypic Switching: Translational Implications for Aneurysm Formation

Krishna Singh - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

N/A

Angiotensin II

Left Main Calcified Lesions as a Strong Predictor of All-Cause Death

Michael Blaha - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Complex calcified coronary artery lesions

N/A

Timing, Profile, and Predictors of Spontaneous Myocardial Infarction Following a Non-ST-Segment Elevation Acute Coronary Syndrome Event: Insights From the TRILOGY-ACS Trial

Benjamin Neely - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Prodromal Symptoms for Acute Coronary Syndrome in Men and Women

Stella Daskalopoulou - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

Grace

Genetic Enhancement of Insulin-Like Growth Factor-1 in Human Cardiac Stem Cells Prevents Cell Death and Enhances Ischemic Myocardial Repair

Everad L Tilokee - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

Mecasermin

Transcatheter Aortic Valve Replacement Improves Functional Status and Quality of Life in Elderly Patients With Severe Aortic Stenosis

Suraj P. Rasania - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Severe Aortic Stenosis

N/A

Congenital Heart Disease and the Emission of Industrial Developmental Toxicants in Alberta, Canada

Lisa K Hornberger - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

Young Women Have a Higher Rate of Myocardial Ischemia Induced by Emotional Stress Than Age-Matched Men After Myocardial Infarction

Amit J. Shah - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

sestamibi

Age Adjusted Health-Related Quality of Life in an ACHD Cohort

Kara Western - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congenital heart disease

N/A

A Prospective Placebo Controlled Randomized Study of Caffeine in Patients With Supraventricular Tachycardia Undergoing Electrophysiological Testing. I. Effects on Cardiac Conduction and Refractoriness

Amanda Pecarskie - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

Caffeine

Contact Force Mapping of Human Cardiac Ganglionnated Plexuses

Robert Lemery - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Increased Circulating Progenitor Cells in Women With Microvascular Coronary Dysfunction: Results From the NHLBI-Sponsored Womens Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction Study (WISE-CVD)

Puja K Mehta - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Acetylcholine

Vagal Nerve Stimulation Modifies Intrinsic Cardiac Local Circuit Neurons in the Suppression of Atrial Arrhythmias

John Andrew Armour - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmia

N/A

Neither Ultraviolet B Light Nor PM2.5 Air Pollution Explain the Association Between Higher Altitude of Residence and Better Outcomes After Myocardial Infarction

Alka B Patel - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Coronary Artery Disease

Ergocalciferol

Mechanics of Mitral Regurgitation in Peripartum Cardiomyopathy

Dennis McNamara - American Heart Association (AHA) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Peripartum cardiomyopathy

N/A

Filters

28841 Abstracts